Spark, Pfizer report progress on gene therapy for hemophilia
May 22, 2018 at 11:43 AM EDT
The clinical testing program is expected to transition to Pfizer from Spark Therapeutics this summer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.